PBF-4554

N/A

Report date: 2022/01/28 16:06:30
NME

Base Information

Drug NamePBF-4554
Drug Alias NamePBF-4554
ClassificationOther
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsTransmembrane protease serine 2 inhibitors
TargetsAngiotensin-converting enzymeTransmembrane protease serine 2
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPalobiofarma Sl
China Registration ClassN/A

Develop Information

Active CompaniesPalobiofarma Sl
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A